<DOC>
	<DOCNO>NCT01886599</DOCNO>
	<brief_summary>The purpose study determine Asunaprevir handle body subject kidney disease compare subject normal kidney function</brief_summary>
	<brief_title>Study Pharmacokinetics Safety Asunaprevir Patients With Kidney Disease</brief_title>
	<detailed_description>Primary Purpose : Other : The purpose study determine Asunaprevir handle body subject kidney disease compare subject normal kidney function</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Group A : Subjects normal renal function Group B : Patients end stage renal disease Group C : Patients mild renal impairment Group D : Patients moderate renal impairment Group E : Patients severe renal impairment History uncontrolled unstable cardiovascular , respiratory , hepatic , gastrointestinal , endocrine , hematopoietic , psychiatric and/or neurological disease Hepatitis B C Human Immunodeficiency Virus ( HIV ) Recent gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>